Email Campaign to Increase Uptake of myGeisinger

April 30, 2021 updated by: Amir Goren, Geisinger Clinic

Email Campaign to Encourage Patients to Complete Sign-up Process for Geisinger's Patient Portal

The purpose of the current study is to test different email messages to determine the most effect way of promoting enrollment in Geisinger's patient portal, called myGeisinger.

Study Overview

Detailed Description

Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, fewer than half of patients have enrolled in Geisinger's patient portal, myGeisinger.

The purpose of the current study is to assess what kind of messaging improves the effectiveness of an email campaign targeted at enrolling patients into Geisinger's online patient portal, called myGeisinger. Currently, Geisinger sends an email every month to patients who have started but not completed the enrollment process (they have had an activation code generated but have not yet used that code to enroll). This study will A/B test 5 email messages to assess if they perform better than the current standard email message.

Performance will be assessed based on whether patients open the email, click on the myGeisinger enrollment link, and enroll in myGeisinger. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.

Study Type

Observational

Enrollment (Actual)

14099

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Danville, Pennsylvania, United States, 17822
        • Geisinger

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 88 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The population consists of Geisinger patients whose myGeisinger status is "Pending" and who have an email address on file.

Description

Inclusion Criteria:

  • Geisinger patients whose myGeisinger status is "Pending", meaning an activation code has been generated for them, but they have not completed activation

Exclusion Criteria:

  • Patients without email addresses on file
  • Patients who received emails from this monthly myGeisinger marketing campaign within the last 2 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Control
A standard marketing message encouraging activation and describing the benefits of myGeisinger
Email
Focused on provider communication
A simple message focused on one benefit of myGeisinger: communicating easily with providers
Email
Focused on scheduling
A simple message focused on one benefit of myGeisinger: scheduling and managing appointments online
Email
Focused on medical information access
A simple message focused on one benefit of myGeisinger: accessing medical information, like test results
Email
Social proof
A message similar to control, but including information about how many other patients are using myGeisinger
Email
Endowment / decision staging

A message similar to control, but framing myGeisinger as something that patients already have, and just need to take one more step to activate.

Endowment: Give patients the impression they already have the account, so they value it more.

Decision staging: Break down the process into multiple stages - "having" an account and "activating" that account- and giving the impression that they are almost there because the first stage is complete

Email

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Email Opened: Control vs. Less-is-better vs. Social Proof vs. Endowment
Time Frame: 8-10 days post-intervention
Whether email was opened (yes / no)
8-10 days post-intervention
Link Clicked: Control vs. Less-is-better vs. Social Proof vs. Endowment
Time Frame: 8-10 days post-intervention
Whether the link / button to start the activation process was clicked (yes / no)
8-10 days post-intervention
Enrollment: Control vs. Less-is-better vs. Social Proof vs. Endowment
Time Frame: 8-10 days post-intervention
Whether the patient enrolled in myGeisinger (yes / no)
8-10 days post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Email Opened: Control vs. Less-is-better vs. Social Proof vs. Endowment
Time Frame: 32-35 days post-intervention
Whether email was opened (yes / no)
32-35 days post-intervention
Link Clicked: Control vs. Less-is-better vs. Social Proof vs. Endowment
Time Frame: 32-35 days post-intervention
Whether the link / button to start the activation process was clicked (yes / no)
32-35 days post-intervention
Enrollment: Control vs. Less-is-better vs. Social Proof vs. Endowment
Time Frame: 32-35 days post-intervention
Whether the patient enrolled in myGeisinger (yes / no)
32-35 days post-intervention
Email Opened: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)
Time Frame: 8-10 days post-intervention
Whether email was opened (yes / no)
8-10 days post-intervention
Link Clicked: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)
Time Frame: 8-10 days post-intervention
Whether the link / button to start the activation process was clicked (yes / no)
8-10 days post-intervention
Enrollment: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)
Time Frame: 8-10 days post-intervention
Whether the patient enrolled in myGeisinger (yes / no)
8-10 days post-intervention
Email Opened: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)
Time Frame: 32-35 days post-intervention
Whether email was opened (yes / no)
32-35 days post-intervention
Link Clicked: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)
Time Frame: 32-35 days post-intervention
Whether the link / button to start the activation process was clicked (yes / no)
32-35 days post-intervention
Enrollment: Within Less-is-better (Provider Communication vs. Managing Appointments vs. Medical Information Access)
Time Frame: 32-35 days post-intervention
Whether the patient enrolled in myGeisinger (yes / no)
32-35 days post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 6, 2020

Primary Completion (ACTUAL)

April 13, 2020

Study Completion (ACTUAL)

May 8, 2020

Study Registration Dates

First Submitted

March 31, 2020

First Submitted That Met QC Criteria

April 1, 2020

First Posted (ACTUAL)

April 2, 2020

Study Record Updates

Last Update Posted (ACTUAL)

May 3, 2021

Last Update Submitted That Met QC Criteria

April 30, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.

IPD Sharing Time Frame

The data will become available after publication of study results in a scientific journal and will be available as long as the Open Science Framework hosts the data.

IPD Sharing Access Criteria

The data on the Open Science Framework will be open to anyone requesting that information.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

Clinical Trials on Standard email

3
Subscribe